Trial · NCT04605393
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Hopkins Verbal Learning Test | Baseline visit; 20 mins post-THC | Delayed verbal recall |
| Primary | Positive and Negative Syndrome Scale | pre-CBD/placebo administration, and from immediately after THC inhalation until the end of study visit (i.e. 2-3 hours post-THC) | Positive Subscale |
| Secondary | State-Trait Anxiety Inventory | pre-CBD/placebo administration, pre-THC and 20mins post-THC | State Scale |
| Secondary | Digit span | Baseline; 25 mins post-THC | Forward \& Reverse |
| Secondary | Hopkins Verbal Learning Test | Baseline; 20 mins post-THC | Immediate verbal recall |
| Secondary | Positive and Negative Syndrome Scale | pre-CBD/placebo administration, and from immediately after THC inhalation until the end of study visit (i.e. 2-3 hours post-THC) | Negative Subscale |
| Secondary | Visual analogue scales | pre-CBD/placebo, 90mins post CBD, pre-THC, and +10mins, +45mins, +90mins post-THC inhalation, and at the end of study visit (i.e. 2-3 hours post-THC) | * Feel drug effect * Like drug effect * Want more drug * Thinking clearly * Tired * Excited * Want to talk * Anxious * Relaxed * Happy * Irritable * Suspicious * Hearing voices * Dry mouth * Hungry |
| Secondary | Psychotomimetic states inventory | pre-CBD/placebo administration, and at the end of study visit (i.e. 2-3 hours post-THC) | |
| Secondary | State Social Paranoia Scale | pre-CBD/placebo administration, and at the end of study visit (i.e. 2-3 hours post-THC) | |
| Secondary | Study drug preference | End of Experiment 2 | At the end of the final experimental visit (i.e. 2-3 hours post-THC), participants will be asked to order the two experimental visits according to which drug combination they found most pleasurable. |
| Secondary | Advice Taking Task | Baseline visit; 30 mins post-THC | |
| Secondary | White Noise Task | Baseline visit; 50 mins post-THC | |
| Secondary | Plasma delta-9-tetrahydrocannabinol (THC) concentration | pre-CBD/placebo, 90mins post CBD, and 0mins, 5mins, 15mins, +90mins post-THC | |
| Secondary | Plasma cannabidiol (CBD) concentration | pre-CBD/placebo, 90mins post CBD, and 0mins, 5mins, 15mins, +90mins post-THC | |
| Secondary | Plasma THC-COOH concentraion | pre-CBD/placebo, 90mins post CBD, and 0mins, 5mins, 15mins, +90mins post-THC | |
| Secondary | Plasma 11-COOH-THC concentration | pre-CBD/placebo, 90mins post CBD, and 0mins, 5mins, 15mins, +90mins post-THC | |
| Secondary | Plasma 11-OH-THC concentration | pre-CBD/placebo, 90mins post CBD, and 0mins, 5mins, 15mins, +90mins post-THC | |
| Secondary | Plasma 6-OH-CBD concentration | pre-CBD/placebo, 90mins post CBD, and 0mins, 5mins, 15mins, +90mins post-THC | |
| Secondary | Plasma anandamide concentration | pre-CBD/placebo, 90mins post CBD, and 0mins, 5mins, 15mins, +90mins post-THC | |
| Secondary | Plasma 2-arachidonoylglycerol concentration. | pre-CBD/placebo, 90mins post CBD, and 0mins, 5mins, 15mins, +90mins post-THC |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04605393/registered